英文名稱 |
中文名稱 |
CAS號 |
操作 |
|
阿哌沙班雜質(zhì)H |
|
詳細(xì)
|
Apixaban Impurity S3 |
阿哌沙班雜質(zhì)S3 |
2098457-93-1 |
詳細(xì)
|
BIS THF HNS Derivative 2 |
BIS THF HNS衍生物2 |
799241-85-3 |
詳細(xì)
|
Captopril EP Impurity A (Captopril Disulfide) |
卡托普利EP雜質(zhì)A(卡托普利二硫化物) |
|
詳細(xì)
|
Captopril EP Impurity G |
卡托普利EP雜質(zhì)G |
33325-40-5 |
詳細(xì)
|
Captopril Related Compound 5 |
卡托普利相關(guān)化合物5 |
74345-73-6 |
詳細(xì)
|
Captopril Impurity 1 |
卡托普利雜質(zhì)1 |
613256-52-3 |
詳細(xì)
|
Captopril Related Compound 10 |
卡托普利相關(guān)化合物10 |
78636-31-4 |
詳細(xì)
|
Bendamustine Impurity G;(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate |
苯達(dá)莫司汀雜質(zhì)G |
|
詳細(xì)
|
BIS THF HNS Derivative 1 |
BIS THF HNS衍生物1 |
253265-98-4 |
詳細(xì)
|
BIS THF Nitro Derivative 2 |
BIS THF硝基衍生物2 |
252873-01-1 |
詳細(xì)
|
BIS THF Nitro Derivative 1 |
BIS THF硝基衍生物1 |
288296-64-0 |
詳細(xì)
|
Bendamustine Impurity D;ethyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate |
苯達(dá)莫司汀雜質(zhì)D |
|
詳細(xì)
|
Tacrolimus EP Impurity A |
子囊霉素(他克莫司相關(guān)化合物A) |
104987-12-4 |
詳細(xì)
|
Atropine Sulfate |
硫酸阿托品 |
55-48-1 |
詳細(xì)
|
Azilsartan iMpurity G |
阿齊沙坦雜質(zhì)G |
|
詳細(xì)
|
Bendamustine Impurity A;4-(5-((2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid |
苯達(dá)莫司汀雜質(zhì)A |
109882-26-0 |
詳細(xì)
|
BIS THF HNS Derivative 3 |
BIS THF HNS衍生物3 |
799241-86-4 |
詳細(xì)
|
Bupropion Impurity B HCl |
安非他酮相關(guān)化合物B HCl |
1049718-43-5 |
詳細(xì)
|
Captopril Impurity F |
卡托普利雜質(zhì)F |
63250-36-2 |
詳細(xì)
|
Hydroxy Bupropion |
羥基安非他酮 |
357399-43-0 |
詳細(xì)
|
Argatroban iMpurity I |
阿加曲班雜質(zhì)I |
|
詳細(xì)
|
Bupropion Impurity 13 |
安非他酮雜質(zhì)13 |
1346603-00-6 |
詳細(xì)
|
Bupropion impurity 16 |
安非他酮雜質(zhì)14(3'-氯苯丙酮) |
34841-35-5 |
詳細(xì)
|
Bupropion Indandione |
安非他酮雜質(zhì)E |
10557-17-2 |
詳細(xì)
|
Captopril EP Impurity G |
卡托普利EP雜質(zhì)G(S-異構(gòu)體) |
76497-39-7 |
詳細(xì)
|
Argatroban iMpurity L |
阿加曲班雜質(zhì)L |
|
詳細(xì)
|
Argatroban iMpurity H |
阿加曲班雜質(zhì)H |
|
詳細(xì)
|
BIS THF Nitro Derivative 3 |
BIS THF硝基衍生物3 |
252873-00-0 |
詳細(xì)
|
Bupropion Impurity 12 HCl |
安非他酮雜質(zhì)12 |
1346598-72-8 |
詳細(xì)
|
Valsartan Methyl Ester |
安非他酮雜質(zhì)11((3S,5S,6S) - 安非他酮雜質(zhì)) |
2133460-42-9 |
詳細(xì)
|
Bupropion impurity 15 |
安非他酮雜質(zhì)(3-氯苯甲酸) |
535-80-8 |
詳細(xì)
|
Riluzole Impurity 5 |
Bromo Riluzole雜質(zhì) |
88149-49-9 |
詳細(xì)
|
Bupropion Impurity 3 |
安非他酮雜質(zhì)3 |
34509-36-9 |
詳細(xì)
|
Bupropion impurity A HCl |
安非他酮相關(guān)化合物A HCl |
1049718-72-0 |
詳細(xì)
|
Bupropion impurity F |
安非他酮相關(guān)化合物F |
857233-13-7 |
詳細(xì)
|
Bupropion Related Compound C |
安非他酮相關(guān)化合物C |
152943-33-4 |
詳細(xì)
|
Bupropion Morpholinol-d6 |
安非他酮雜質(zhì)-d6 |
1216893-18-3 |
詳細(xì)
|
Captopril Related Compound 7 |
卡托普利雜質(zhì)10 |
65167-28-4 |
詳細(xì)
|
Captopril Related Compound 6 |
卡托普利相關(guān)化合物6 |
69570-39-4 |
詳細(xì)
|
Captopril EP Impurity J |
卡托普利EP雜質(zhì)J |
64838-55-7 |
詳細(xì)
|
Bupropion-d9 HCl |
安非他酮-d9 HCl |
1189725-26-5 |
詳細(xì)
|
Valsartan Methyl Ester |
安非他酮雜質(zhì)ABCDEFGH |
2133460-43-0 |
詳細(xì)
|
Bupropion impurity M1-9 |
安非他酮雜質(zhì)M1-9 |
34911-51-8 |
詳細(xì)
|
Azilsartan iMpurity M |
阿齊沙坦雜質(zhì)M |
|
詳細(xì)
|
Captopril EP Impurity H |
卡托普利EP雜質(zhì)H |
205521-07-9 |
詳細(xì)
|
Captopril Impurity 2 |
卡托普利雜質(zhì)2 |
112243-88-6 |
詳細(xì)
|
Azilsartan Impurity M |
阿齊沙坦雜質(zhì)N |
2244031-86-3 |
詳細(xì)
|
Captopril EP Impurity C |
卡托普利EP雜質(zhì)C |
26473-47-2 |
詳細(xì)
|
Captopril EP Impurity N |
卡托普利雜質(zhì)4 |
65134-74-9 |
詳細(xì)
|
Captopril EP Impurity D |
卡托普利EP雜質(zhì)D |
56970-78-6 |
詳細(xì)
|
Apixaban Impurity 82 |
阿哌沙班雜質(zhì)82+ |
|
詳細(xì)
|
Argatroban iMpurity K |
阿加曲班雜質(zhì)K |
|
詳細(xì)
|
Darunavir Ethanolate |
地瑞那韋雜質(zhì) |
635728-49-3 |
詳細(xì)
|
Darunavir Impurity 10 |
達(dá)魯那韋雜質(zhì)9 |
1932330-83-0 |
詳細(xì)
|
Dapoxetine impurity 37 |
安非他酮雜質(zhì) |
936-59-4 |
詳細(xì)
|
Cinacalcet impurity 7 |
西那卡塞雜質(zhì)19 |
1428118-39-1 |
詳細(xì)
|
Clozapine EP Impurity C |
氯氮平EP雜質(zhì)C |
6104-71-8 |
詳細(xì)
|
Glycine impurity 11 |
氯吡格雷雜質(zhì)9 |
532987-11-4 |
詳細(xì)
|
Cinacalcet impurity 21;N-(1-(5,6-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide hydrochloride |
西那卡塞雜質(zhì)21 |
|
詳細(xì)
|
Clozapine EP Impurity C-d8 (N-Desmethyl Clozapine-d8) |
氯氮平-d8 |
1185053-50-2 |
詳細(xì)
|
Clozapine EP Impurity C-d8 (N-Desmethyl Clozapine-d8) |
氯氮平-d4 |
204395-52-8 |
詳細(xì)
|
Clopidogrel Metabolite 1;(E)-2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-mercaptopiperidin-3-ylidene)acetic acid |
氯吡格雷代謝物1 |
|
詳細(xì)
|
Cinacalcet impurity 20;N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide hydrochloride |
西那卡塞雜質(zhì)20 |
|
詳細(xì)
|
Cinacalcet impurity 18;(E)-N-(1-(5,6-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)acrylamide hydrochloride |
西那卡塞雜質(zhì)18 |
802918-35-0 |
詳細(xì)
|
Captopril Related Compound 9 |
卡托普利相關(guān)化合物9 |
75479-46-8 |
詳細(xì)
|
Captopril-d3 |
卡托普利雜質(zhì) |
1356383-38-4 |
詳細(xì)
|
Cinacalcet impurity 22;(E)-N-(1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)acrylamide hydrochloride |
西那卡塞雜質(zhì)22 |
|
詳細(xì)
|
Clevidipine Butyrate Impurity 9;3-((butyryloxy)methyl) 5-methyl 4-(3,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
丁酸氯維地平雜質(zhì)9 |
|
詳細(xì)
|
Clozapine-5-N-Glucuronide Sodium Salt |
氯氮平-5- N-葡糖苷酸鈉鹽 |
390651-03-3 |
詳細(xì)
|
Creatine Phosphate Sodium Impurity 9;2-(3-(bis(benzyloxy)phosphoryl)-1-methylguanidino)acetic acid |
磷酸肌酸鈉雜質(zhì)9 |
|
詳細(xì)
|
Dilinavir |
地瑞那韋雜質(zhì) |
206361-99-1 |
詳細(xì)
|
Clozapine EP Impurity A |
氯氮平EP雜質(zhì)A |
50892-62-1 |
詳細(xì)
|
Clopidogrel Bisulfate Impurity 33 |
氯吡格雷雜質(zhì)13 |
2173294-69-2 |
詳細(xì)
|
Darunavir Impurity 11 |
達(dá)魯那韋雜質(zhì)10 |
1932353-11-1 |
詳細(xì)
|
Darunavir Impurity 12 |
達(dá)魯那韋雜質(zhì)11 |
866594-60-7 |
詳細(xì)
|
Darunavir Impurity 13 |
達(dá)魯那韋雜質(zhì)12 |
156636-67-8 |
詳細(xì)
|
Darunavir Impurity 14 |
達(dá)魯那韋雜質(zhì)13 |
143224-62-8 |
詳細(xì)
|
Cefoperazone impurity 30. |
頭孢哌酮鈉 |
62893-20-3 |
詳細(xì)
|
Clozapine-d3 |
氯氮平-d3 |
1215691-72-7 |
詳細(xì)
|
Creatine Phosphate Sodium Impurity 3;2-(3-cyano-1-methylguanidino)acetic acid |
磷酸肌酸鈉雜質(zhì)3 |
|
詳細(xì)
|
Creatine Phosphate Sodium Impurity 8;benzyl hydrogen (1-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)phosphoramidate |
磷酸肌酸鈉雜質(zhì)8 |
|
詳細(xì)
|
Creatine Phosphate Sodium Impurity 1; sodium N-methylcarbamimidoylphosphoramidate |
磷酸肌酸鈉雜質(zhì)1 |
|
詳細(xì)
|
Creatine Phosphate Sodium Impurity 13;dibenzyl (1-methyl-4-oxoimidazolidin-2-ylidene)phosphoramidate |
磷酸肌酸鈉雜質(zhì)13 |
|
詳細(xì)
|
Creatine Phosphate Sodium Impurity 10;2-(3-((benzyloxy)(hydroxy)phosphoryl)-1-methylguanidino)acetic acid |
磷酸肌酸鈉雜質(zhì)10 |
|
詳細(xì)
|
Darunavir Impurity 15 |
達(dá)魯那韋雜質(zhì)14 |
1418639-27-6 |
詳細(xì)
|
Clopidogrel Impurity 2;5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-6,7-dihydrothieno[3,2-c]pyridin-5-ium bromide |
氯吡格雷雜質(zhì)2 |
|
詳細(xì)
|
Clopidogrel Impurity 1;5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium chloride |
氯吡格雷雜質(zhì)1 |
|
詳細(xì)
|
Captopril |
卡托普利雜質(zhì) |
62571-86-2 |
詳細(xì)
|
Glycine impurity 10 |
氯吡格雷雜質(zhì)10 |
43189-20-4 |
詳細(xì)
|
|
氯吡格雷雜質(zhì)11 |
|
詳細(xì)
|
|
氯吡格雷雜質(zhì)12 |
|
詳細(xì)
|
Conivaptan impurity F |
考尼伐坦雜質(zhì)F |
|
詳細(xì)
|
Cleviprex Impurity 8 |
丁酸氯維地平雜質(zhì)8 |
|
詳細(xì)
|
Clopidogrel Impurity 49 |
氯吡格雷雜質(zhì)14 |
5402-55-1 |
詳細(xì)
|
Argatroban iMpurity J |
阿加曲班雜質(zhì)J |
|
詳細(xì)
|
Dabigatran Etexilate iMpurity P |
達(dá)比加群酯雜質(zhì)P |
|
詳細(xì)
|
Dabigatran Etexilate iMpurity K |
達(dá)比加群酯雜質(zhì)K |
|
詳細(xì)
|
(R)-N-(1-(naphthalen-2-yl)ethyl) |
西那卡塞雜質(zhì)10 |
|
詳細(xì)
|
Dabigatran Etexilate iMpurity Q |
達(dá)比加群酯雜質(zhì)Q |
|
詳細(xì)
|